Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

The Cardiac Dimensions Carillon Mitral Contour System is a minimally invasive mitral regurgitation therapy made possible by ...

AdvaMed said Trump's new import taxes could cause supply chain disruptions that will increase prices and reduce access to ...

"It’s truly a dream role, and I can’t wait for what’s ahead," said Field, who's now chief technology officer at medtech ...

Edwards Lifescienes also reported a big increase in pay for the structural heart device developer and manufacturer's median ...

Integer Holdings added Lindsay Krause Blackwood and Sanjiv Arora to the contract development and manufacturing organization's ...

Nelipak said it is strengthening its capabilities in the Asia-Pacific region by expanding expertise, technologies, and ...

A study at Rice University found that miniaturization of thin film material can open the door to a new generation of ...

The SpaceXray project has released an image of the first X-ray taken from space, taken aboard SpaceX's Fram2 mission.

Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.

"It would not be surprising if we saw longer review times, at least in the near term," Shuren said about the FDA layoffs.

Steris leaders told an investment firm they are "reluctant to expand capacity until the EO regulations are sorted out." ...